Frontiers in Immunology (Apr 2017)

Nanomaterials in the Context of Type 2 Immune Responses—Fears and Potentials

  • Albert Duschl,
  • Martin Himly,
  • Robert Mills-Goodlet,
  • Mark Geppert

DOI
https://doi.org/10.3389/fimmu.2017.00471
Journal volume & issue
Vol. 8

Abstract

Read online

The type 2 immune response is an adaptive immune program involved in defense against parasites, detoxification, and wound healing, but is predominantly known for its pathophysiological effects, manifesting as allergic disease. Engineered nanoparticles (NPs) are non-self entities that, to our knowledge, do not stimulate detrimental type 2 responses directly, but have the potential to modulate ongoing reactions in various ways, including the delivery of substances aiming at providing a therapeutic benefit. We review, here, the state of knowledge concerning the interaction of NPs with type 2 immune responses and highlight their potential as a multifunctional platform for therapeutic intervention.

Keywords